SQ-LIP-000007 · v1.3 (archived) · View current version →
Is lipedema associated with thyroid disease?
Based on currently indexed evidence, lipedema appears to be associated with elevated rates of thyroid disease, particularly hypothyroidism and chronic autoimmune thyroiditis. Multiple cross-sectional cohorts and surveys consistently report higher thyroid disorder prevalence in lipedema patients compared to general population estimates or lymphedema controls: a German survey (n=209) found hypothyroidism in 35.9% of lipedema patients; a large Spanish cohort (n=1803) identified thyroid disorders as a common comorbidity; an Italian cohort (n=360) reported elevated rates of chronic autoimmune thyroiditis specifically; and a comparative cohort found thyroid disease in 24.4% of lipedema vs 14.89% of lymphedema patients. Cross-national data show variable but consistently notable hypothyroidism rates, including 19.4% in a Brazilian cohort. Importantly, the strongest methodological signal so far comes from the Brazilian cross-sectional screening study, which—although it found hypothyroidism common in raw terms (19.4%)—reported that hypothyroidism was NOT an independent factor associated with lipedema on multivariate analysis (p=0.141), suggesting the observed co-occurrence may reflect confounding (e.g. by obesity) rather than a true independent association. All supporting studies are observational (cross-sectional or retrospective cohort) and rated low-to-moderate quality, with no randomized or prospective controlled designs. Apart from the single Brazilian multivariate analysis, no study has adequately adjusted for confounders such as BMI, sex, healthcare-seeking behavior, or background population thyroid disease prevalence, and none establishes causality or direction of association. The evidence is consistent in direction across multiple populations at the descriptive level but remains preliminary, and the one study that formally tested independence did not confirm it.
Knowledge freshness = share of the 6 indexed evidence sources from the last 5 years (newest 2025, oldest 2019) . Low freshness flags an ageing evidence base — not that the answer is wrong.
Evidence over time
supporting contradicting refining / context Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline. The hollow ring marks the first time this topic appears in the literature.
Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.
What changed in this version
Answer recompiled after human curation of the claim set.
Supporting claims
- SCR-LIP-000020 supporting
Thyroid disorders may be more frequent in lipedema than in lymphedema, with a cross-sectional cohort reporting thyroid disease in 24.4% of lipedema vs 14.89% of lymphedema patients.
Lipedema and Hypermobility Spectrum Disorders Sharing Pathophysiology: A Cross-Sectional Observational Study — Fiengo & Sbarbati (2025) - SCR-LIP-000134 supporting
In a survey of 209 German women with lipedema who underwent liposuction, hypothyroidism was present in 35.9% of participants, a frequency described as far beyond the average prevalence in the general German population.
New Insights on Lipedema: The Enigmatic Disease of the Peripheral Fat — Bauer et al. (2019) · Disease progression and comorbidities in lipedema patients: A 10‐year retrospective analysis — Ghods et al. (2020) - SCR-LIP-000135 supporting
In a cohort of 1803 lipedema patients in Spain, thyroid disorders were reported as a common comorbidity alongside other inflammatory and connective tissue conditions.
Clinical Signs at Diagnosis and Comorbidities in a Large Cohort of Patients with Lipedema in Spain — Simarro Blasco et al. (2025) - SCR-LIP-000136 supporting
In a cohort of 360 Italian women with lipedema, the prevalence of chronic autoimmune thyroiditis was higher compared to the general population.
Observational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported History — Patton et al. (2024)
Contradictory claims
- None indexed yet.
Refining / context
- SCR-LIP-000137 refines
In a Brazilian cross-sectional screening study, hypothyroidism was common in women with lipedema (crude prevalence 19.4%) but was NOT an independent factor associated with lipedema on multivariate analysis (p=0.141) — the raw co-occurrence may reflect confounding (e.g. by obesity) rather than a true independent association.
Lipedema prevalence and risk factors in Brazil — Amato et al. (2022)
Major uncertainty
Whether the consistently reported co-occurrence of thyroid disease and lipedema reflects a true independent association or is confounded (notably by obesity/BMI, sex, and healthcare-seeking behavior) remains unresolved. The only study to formally test independence (Brazilian, multivariate) found hypothyroidism was NOT independently associated with lipedema (p=0.141), directly challenging the descriptive co-occurrence signal. No prospective, controlled, or adequately confounder-adjusted studies exist to establish causality or direction.
Version history
- SQ-LIP-000007 · v1.3 — 2026-05-31 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000007 · v1.2 — 2026-05-31 — This update added cross-national comparative data from Brazilian, Polish, and Dutch cohorts showing variable but consistently notable hypothyroidism prevalence rates in lipedema patients (19.4%, 31.6%, and 11.7%, respectively), reinforcing the cross-population consistency of the association while highlighting inter-cohort variability. · view this version
- SQ-LIP-000007 · v1.1 — 2026-05-31 — This update substantially strengthened the evidence base by adding three new cohorts (n=209 German, n=1803 Spanish, n=360 Italian) that consistently report elevated thyroid disorder prevalence—including specifically chronic autoimmune thyroiditis—in lipedema patients, upgrading two claims to moderate quality and broadening the finding beyond a single comparison cohort. · view this version
- SQ-LIP-000007 · v1.0 — 2026-05-30 — founding index (5 claims) · view this version
Key references
DOI:10.3390/jcm14207195 · DOI:10.1097/prs.0000000000006280 · DOI:10.1111/dth.14534 · DOI:10.3390/biomedicines13123049 · DOI:10.3390/ijms25031599 · DOI:10.1590/1677-5449.202101982